Viewing Study NCT00320359


Ignite Creation Date: 2025-12-24 @ 2:35 PM
Ignite Modification Date: 2026-01-01 @ 6:12 PM
Study NCT ID: NCT00320359
Status: COMPLETED
Last Update Posted: 2017-03-01
First Post: 2006-05-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung Cancer
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module